Lmao yeah as if trialing 3 ART opioids and staring a human liability trial that has already had success with Eli 216. Elite has more ART trials in motion then any other drug company. Elit is doing and moving just fine. $$$$$
Purdue was smart enough NOT to pursue a 1-bead Embeda whereas Pfizer/King/Alparma were not. So now opportunistic Purdue after many years of "bad guy" image with Oxycontin is suddenly trying to portray the White Knight image with Hydrocodone. Alas Purdue remains the Black Knight fooling no one with its easily defeated physical barrier opioid drugs.
$ELTP with its triple patented Pharmacological ADTs ELI200/201/202/216 are the answers that the FDA wants.
Market Data 
Markets 
AI
